supp.fit

Lutein: study protocols

158 study groups say how much Lutein participants took a day. These are the doses the studies gave. They are not a recommendation.

Lutein: what the research found →

Dose per serving from products

3,482 products in our catalogue print how much Lutein a serving holds.

Most common: 10 mg to 25 mg, 26% of 3,482 products.

Dose per servingProducts
100 mcg or less
171
100 mcg to 250 mcg
269
250 mcg to 500 mcg
370
500 mcg to 1 mg
200
1 mg to 2.5 mg
192
2.5 mg to 5 mg
434
5 mg to 10 mg
720
10 mg to 25 mg
916
25 mg to 50 mg
160
over 50 mg
50

Dose per serving from research

158 study groups in 99 studies say how much Lutein participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg to 10 mg, 53% of 158 study groups.

Daily doseStudy groups
1 mg or less
3
1 mg to 2.5 mg
7
2.5 mg to 5 mg
12
5 mg to 10 mg
84
10 mg to 25 mg
50
over 25 mg
2

Commonly used together

104 of 158 study groups took Lutein with something else. Shown: what 3 or more different studies gave. The 10 most common of 13.

What was given together, not what works together.

Taken withStudy groups
Zeaxanthin
81
Meso-Zeaxanthin
16
Vitamin E
16
Omega-3 Fatty Acids
15
Docosahexaenoic Acid
11
Vitamin C
9
Zinc
8
Beta-Carotene
4
Copper
4
Fish Oil
4

158 study groups

Study
Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration
2015 · 10 mg lutein · Adults aged over 50 with clinically diagnosed early age-related macular degeneration
10 mg2 years28
Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration
2015 · 20 mg lutein · Adults aged over 50 with clinically diagnosed early age-related macular degeneration
20 mg2 years28
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial
2012 · 10 mg/d lutein · People with early age-related macular degeneration; age range and sex not reported
10 mg48 weeks27
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial
2012 · 20 mg/d lutein · People with early age-related macular degeneration; age range and sex not reported
20 mg48 weeks27
A 12-week lutein supplementation improves visual function in Chinese people with long-term computer display light exposure
2009 · Group L12 · Healthy adults aged 22–30 years with long-term computer display light exposure
12 mg12 weeks13
Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women
2008 · Lutein · Women aged 60–80 years without stated cognitive impairment
12 mg120 days11
Lutein supplementation improves visual performance in Chinese drivers: 1-year randomized, double-blind, placebo-controlled study
2013 · active (A) group · healthy drivers with long-term light exposure
20 mg1 year—
Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy
2017 · lutein group · Patients with nonproliferative diabetic retinopathy; age and sex not stated
10 mg36 weeks—
Lutein supplementation combined with a low-calorie diet in middle-aged obese individuals: effects on anthropometric indices, body composition and metabolic parameters
2021 · lutein group · Adults aged 45–65 years with obesity, following a low-calorie diet
20 mg10 weeks—
A 12-week lutein supplementation improves visual function in Chinese people with long-term computer display light exposure
2009 · Group L6 · Healthy adults aged 22–30 years with long-term computer display light exposure
6 mg12 weeks12
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
2013 · lutein + zeaxanthin group · Adults aged 50 to 85 years at risk for progression to advanced age-related macular degeneration, with bilateral large drusen or large drusen in one eye and advanced AMD in the fellow eye
10 mg5 years—
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3
2014 · lutein/zeaxanthin · Adults with high risk of progression to late age-related macular degeneration; mean age 73.1 years; sex not specified
10 mg1789 days—
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
2019 · Lutein and zeaxanthin addition · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye
10 mg5 years—
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
2013 · lutein + zeaxanthin and DHA + EPA group · Adults aged 50 to 85 years at risk for progression to advanced age-related macular degeneration, with bilateral large drusen or large drusen in one eye and advanced AMD in the fellow eye
10 mg5 years—
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3
2014 · lutein/zeaxanthin and DHA/EPA · Adults with high risk of progression to late age-related macular degeneration; mean age 73.1 years; sex not specified
10 mg1789 days—
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
2019 · Lutein and zeaxanthin plus omega-3 fatty acids · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye
10 mg5 years—
Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
2018 · active group · Healthy individuals with low macular pigment levels; mean age 45.42 years, 51.6% male
10 mg1 year45
Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults
2017 · active supplement group · Healthy adults aged 18–30 years, college students, without a stated diagnosed condition
10 mg1 year37
Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial
2023 · active group · Healthy Japanese males and females aged 20–60 years who routinely used visual display terminals or played video games
10 mg8 weeks32
Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration
2015 · lutein (10 mg) + zeaxanthin (10 mg) · Adults aged over 50 with clinically diagnosed early age-related macular degeneration
10 mg2 years28
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial
2012 · 10 mg/d lutein plus 10 mg/d zeaxanthin · People with early age-related macular degeneration; age range and sex not reported
10 mg48 weeks27
Increases in plasma lutein through supplementation are correlated with increases in physical activity and reductions in sedentary time in older adults
2014 · Lutein · Adults aged 55–80 who were not obese and did not meet physical activity guidelines
21 mg4 weeks19
Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women
2008 · Combination of DHA and lutein · Women aged 60–80 years without stated cognitive impairment
12 mg120 days14
Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema
2003 · carotenoid mix · Volunteers with skin type II
8 mg12 weeks12
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A
2010 · lutein + A group · Adults with retinitis pigmentosa
12 mg4 years—
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial
2015 · Lutein/zeaxanthin · Older adults with intermediate or late age-related macular degeneration; mean age about 73 years, both sexes
10 mg5 years—
Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population
2013 · A+L · Adults with early atherosclerosis
20 mg90 days34
Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy
2014 · lutein group · Patients with central serous chorioretinopathy (age range and sex not stated)
20 mg120 days20
Lutein ester in serum after lutein supplementation in human subjects
1998 · lutein supplementation · Apparently healthy, non-smoking adults aged 25–45 years; nine men and nine women
15 mg120 days18
Randomized, Placebo-Controlled, Single-Blind Study of Lutein Supplementation on Carotenoid Status and Cognition in Persons with Multiple Sclerosis
2023 · treatment · Adults with relapsing-remitting multiple sclerosis
20 mg120 days12
Comparison of dietary supplementation with lutein diacetate and lutein: a pilot study of the effects on serum and macular pigment
2012 · Group 1 (lutein diacetate) · Study subjects; age, sex, and health condition are not reported.
20 mg24 weeks10
Comparison of dietary supplementation with lutein diacetate and lutein: a pilot study of the effects on serum and macular pigment
2012 · Group 2 (lutein) · Study subjects; age, sex, and health condition are not reported.
20 mg24 weeks10
Comparison of macular pigment and serum lutein concentration changes between free lutein and lutein esters supplements in Japanese subjects
2016 · free lutein group · Healthy Japanese adults aged 22–47 years
10 mg90 days10
Comparison of macular pigment and serum lutein concentration changes between free lutein and lutein esters supplements in Japanese subjects
2016 · lutein esters group · Healthy Japanese adults aged 22–47 years
20 mg90 days10
A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses
2002 · Lutein from marigold extracts · Healthy men and women aged 25–45 years from five European regions
15 mg——
Dose-ranging study of lutein supplementation in persons aged 60 years or older
2006 · 10-mg lutein group · Adults aged 60 years or older, with no AMD, large drusen, or advanced AMD
10 mg26 weeks—
The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation
2008 · lutein · Women aged 60–80 years
12 mg120 days—
Serum lutein and its dynamic changes during supplementation with lutein in Chinese subjects
2009 · 12 mg lutein/d group · Healthy Chinese subjects; age and sex range not specified
12 mg12 weeks—
Serum lutein response is greater from free lutein than from esterified lutein during 4 weeks of supplementation in healthy adults
2010 · free lutein (fL) group · Adults aged 23–52 years with baseline serum lutein below 20 µg/dL and BMI above 20 and below 30 kg/m²
12.2 mg4 weeks—
Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging
2012 · Lutein group · Healthy Japanese volunteers; age range and sex distribution not specified
10 mg90 days—
Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration
2013 · low lutein (LL) · Chinese patients older than 50 years with early age-related macular degeneration
10 mg48 weeks—
Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration
2013 · high lutein (HL) · Chinese patients older than 50 years with early age-related macular degeneration
20 mg48 weeks—
Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers
2013 · 10 mg/d lutein group · Healthy nonsmokers; age and sex not specified
10 mg12 weeks—
Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers
2013 · 20 mg/d lutein group · Healthy nonsmokers; age and sex not specified
20 mg12 weeks—
Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults
2023 · LCPUFAs + LZ group, Trial 2 · Healthy Japanese adults aged 55–79 with memory complaints and no dementia; cognitive-decline subgroup had MoCA-J scores below 23
10 mg12 weeks96
Enhanced physical and cognitive performance in active duty Airmen: evidence from a randomized multimodal physical fitness and nutritional intervention
2020 · exercise plus nutritional supplement group · Active-duty Air Force Airmen aged 18–45; no qualifying disease or deficiency was stated
12 mg12 weeks70
Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults
2023 · LCPUFAs + LZ group, Trial 1 · Healthy Japanese adults aged 55–79 with memory complaints and no dementia; cognitive-decline subgroup had MoCA-J scores below 23
10 mg24 weeks40
TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD
2007 · Sham MCS and nutritional supplement · Adults aged 50–90 with dry age-related macular degeneration in at least one eye
8 mg24 weeks37
Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial
2022 · active group · Cognitively healthy adults aged 65 years and older
10 mg2 years30
Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula
2020 · LM group · Adults aged 54–80 with retinal drusen and risk of age-related macular degeneration
15 mg26 weeks29
Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula
2020 · PV group · Adults aged 54–80 with retinal drusen and risk of age-related macular degeneration
10 mg26 weeks20
Consumption of Nutritionally Enriched Hen Eggs Enhances Endothelium-Dependent Vasodilation via Cyclooxygenase Metabolites in Healthy Young People-A Randomized Study
2023 · Nutri4 (enriched eggs) · Healthy young adults aged 18–30 years, both sexes, with normal blood pressure and BMI
1.85 mg3 weeks20
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year
2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years
10 mg1 year15
Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up
2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years
20 mg26 weeks15
Beneficial Effects of Micronutrient Supplementation in Restoring the Altered Microbiota and Gut-Retina Axis in Patients with Neovascular Age-Related Macular Degeneration-A Randomized Clinical Trial
2024 · intervention group · Adults with neovascular age-related macular degeneration; mean age 77.8 years
10 mg26 weeks15
Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans
2011 · Active group · People with subjective symptoms of asthenopia; age and sex not reported
17.5 mg4 weeks11
Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study
2012 · treated group · Patients with age-related macular degeneration; age and sex not stated
10 mg2 years—
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial
2015 · DHA/EPA and lutein/zeaxanthin · Older adults with intermediate or late age-related macular degeneration; mean age about 73 years, both sexes
10 mg5 years—
Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial
2024 · intervention group · Adults aged 18 years or older with dry eye symptoms
6 mg20 days—
Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
2014 · 20 mg lutein/d · Chinese adults aged 45–68 with subclinical atherosclerosis
20 mg1 year48
Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study
2013 · L group · Adults with early age-related macular degeneration; mean age 70.5 years; sex not reported
10 mg1 year36
The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d
2013 · lutein · Men and women aged 50–80 with early signs of age-related macular degeneration
10 mg1 year35
Clinical Effects of Dietary Supplementation of Lutein with High Bio-Accessibility on Macular Pigment Optical Density and Contrast Sensitivity: A Randomized Double-Blind Placebo-Controlled Parallel-Group Comparison Trial
2020 · lutein group · Healthy adult men and women aged 20–69 years
12 mg16 weeks31
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration
2012 · 10 mg/day lutein · Adults aged 50–79 with early age-related macular degeneration
10 mg48 weeks27
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration
2012 · 20 mg/day lutein · Adults aged 50–79 with early age-related macular degeneration
20 mg48 weeks27
Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults
2010 · lutein group · Men and postmenopausal women aged 50–70 years in good health
12 mg16 weeks20
Epilutein for Early-Stage Age-Related Macular Degeneration: A Randomized and Prospective Study
2017 · group 2 · Adults with early-stage age-related macular degeneration; mean age 72.0 years; sex not reported
10 mg60 days16
Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial
2023 · lutein group · Adults aged 20–50 years with high myopia (axial length 26.5 mm to less than 30.0 mm)
20 mg26 weeks15
Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial)
2004 · Group 1 (L) · Patients with atrophic age-related macular degeneration; age and sex not specified
10 mg1 year—
Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women
2006 · lutein · Healthy, nonsmoking postmenopausal women aged 50–70 years
12 mg8 weeks—
LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls
2007 · group 1 · patients with atrophic age-related macular degeneration; age and sex not specified
10 mg1 year—
Lutein supplementation leads to decreased soluble complement membrane attack complex sC5b-9 plasma levels
2015 · lutein group · Elderly patients with signs of early age-related macular degeneration (AMD)
10 mg1 year—
Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial
2015 · 10 mg lutein · Patients with early age-related macular degeneration
10 mg2 years—
Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial
2015 · 20 mg lutein · Patients with early age-related macular degeneration
20 mg2 years—
Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids
2015 · lutein and antioxidant supplement · Patients with age-related maculopathy
10 mg26 weeks—
Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial
2025 · lutein supplementation group · Adults with central obesity; age and sex not specified
10 mg32 weeks—
Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans
2000 · lutein esters group · Volunteers; age, sex, and health status not specified
8 mg2 weeks—
Dose-ranging study of lutein supplementation in persons aged 60 years or older
2006 · 5-mg lutein group · Adults aged 60 years or older, with no AMD, large drusen, or advanced AMD
5 mg26 weeks—
Lutein bioavailability from lutein ester-fortified fermented milk: in vivo and in vitro study
2010 · High-fortification fermented milk · Volunteers; age, sex, and health status not specified
8 mg2 weeks—
Serum lutein and its dynamic changes during supplementation with lutein in Chinese subjects
2009 · 6 mg lutein/d group · Healthy Chinese subjects; age and sex range not specified
6 mg12 weeks—
Serum lutein response is greater from free lutein than from esterified lutein during 4 weeks of supplementation in healthy adults
2010 · lutein esters (Le) group · Adults aged 23–52 years with baseline serum lutein below 20 µg/dL and BMI above 20 and below 30 kg/m²
27 mg4 weeks—
Effect of Lutein Ester Supplement on Choroidal Thickness in Children: A Randomized Controlled Trial
2025 · Treatment group · Children aged 8–12 years, including children with normal vision and poor vision
8 mg26 weeks90
Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
2014 · 20 mg lutein/d+20 mg lycopene/d · Chinese adults aged 45–68 with subclinical atherosclerosis
20 mg1 year48
Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study
2020 · Beeswax capsule group · Adults with unilateral exudative age-related macular degeneration; mean age 69.5 years, 13 men and 7 women
20 mg26 weeks20
Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study
2020 · Glycerol fatty acid esters capsule group · Adults with unilateral exudative age-related macular degeneration; mean age 72.0 years, 11 men and 8 women
20 mg26 weeks19
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973
2011 · 9 mg L ("Faux Placebo," control group) · Patients with mild-to-moderate age-related macular degeneration, mean age 74.9 years; 57 men and 3 women across the study
9 mg1 year10
Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial)
2004 · Group 2 (L/A) · Patients with atrophic age-related macular degeneration; age and sex not specified
10 mg1 year—
LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls
2007 · group 2 · patients with atrophic age-related macular degeneration; age and sex not specified
10 mg1 year—
Lutein and beta-carotene from lutein-containing yellow carrots are bioavailable in humans
2004 · lutein supplement (LS treatment) · Women and men aged 23–28; no condition reported
1.7 mg7 days9
Dose-ranging study of lutein supplementation in persons aged 60 years or older
2006 · 2.5-mg lutein group · Adults aged 60 years or older, with no AMD, large drusen, or advanced AMD
2.5 mg26 weeks—
Effect of Spinacia oleraceae L. and Perilla frutescens L. on antioxidants and lipid peroxidation in an intervention study in healthy individuals
2010 · Spinach preparation · Healthy volunteers; age and sex not reported
5 mg10 days—
Effect of Spinacia oleraceae L. and Perilla frutescens L. on antioxidants and lipid peroxidation in an intervention study in healthy individuals
2010 · Perilla preparation · Healthy volunteers; age and sex not reported
5 mg10 days—
Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial
2013 · intervention group · Adults with early age-related macular degeneration; mean age 69.2 years, both sexes
12 mg1 year23
A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast
2014 · L+Z · Young, healthy subjects; age and sex not specified
10 mg1 year57
A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiency
2014 · Multi · Healthy adults aged 18–32 years
8 mg120 days25
Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults
2021 · treatment group · Older US veterans with difficulty seeing at night, without overt ocular disease; mean age 62.7 years
7 mg26 weeks24
Bioavailability of Lutein from Marigold Flowers (Free vs. Ester Forms): A Randomised Cross-Over Study to Assess Serum Response and Visual Contrast Threshold in Adults
2024 · Free lutein · Apparently healthy men and women aged 20–35 and 50–65 years
6 mg60 days24
Bioavailability of Lutein from Marigold Flowers (Free vs. Ester Forms): A Randomised Cross-Over Study to Assess Serum Response and Visual Contrast Threshold in Adults
2024 · Lutein ester · Apparently healthy men and women aged 20–35 and 50–65 years
6 mg60 days24
The effect of modified eggs and an egg-yolk based beverage on serum lutein and zeaxanthin concentrations and macular pigment optical density: results from a randomized trial
2014 · Lutein Egg · Healthy adults aged 18 years and older with macular pigment optical density below 0.55
921 mcg90 days20
The effect of modified eggs and an egg-yolk based beverage on serum lutein and zeaxanthin concentrations and macular pigment optical density: results from a randomized trial
2014 · Zeaxanthin Egg · Healthy adults aged 18 years and older with macular pigment optical density below 0.55
174 mcg90 days20
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment
2012 · Group 1 · Healthy subjects with atypical macular pigment spatial profiles; age and sex not stated
20 mg8 weeks10
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment
2012 · Group 2 · Healthy subjects with atypical macular pigment spatial profiles; age and sex not stated
10 mg8 weeks10
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment
2012 · Group 3 · Healthy subjects with atypical macular pigment spatial profiles; age and sex not stated
3 mg8 weeks10
Plasma kinetics of lutein, zeaxanthin, and 3-dehydro-lutein after multiple oral doses of a lutein supplement
2005 · group 1 · healthy volunteers
4.1 mg6 weeks8
Plasma kinetics of lutein, zeaxanthin, and 3-dehydro-lutein after multiple oral doses of a lutein supplement
2005 · group 2 · healthy volunteers
20.5 mg6 weeks8
Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin C) on alpha-tocopherol absorption
2007 · Meal containing 18 mg lutein · Healthy men; age not reported
18 mg1 day8
Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin C) on alpha-tocopherol absorption
2007 · Meal containing 36 mg lutein · Healthy men; age not reported
36 mg1 day8
The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older
2006 · 2.5 mg/d lutein group · Adults aged 60 or older, with or without age-related macular degeneration
2.5 mg180 days—
The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older
2006 · 5.0 mg/d lutein group · Adults aged 60 or older, with or without age-related macular degeneration
5 mg180 days—
The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older
2006 · 10 mg/d lutein group · Adults aged 60 or older, with or without age-related macular degeneration
10 mg180 days—
The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation
2008 · lutein + DHA · Women aged 60–80 years
12 mg120 days—
Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration
2013 · Group 1 · Adults with or without age-related macular degeneration; age and sex not reported
20 mg8 weeks—
Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration
2013 · Group 2 · Adults with or without age-related macular degeneration; age and sex not reported
10 mg8 weeks—
Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration
2013 · Group 3 · Adults with or without age-related macular degeneration; age and sex not reported
3 mg8 weeks—
Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration
2013 · lutein plus zeaxanthin (LZ) · Chinese patients older than 50 years with early age-related macular degeneration
10 mg48 weeks—
Age-related macular degeneration: Effects of a short-term intervention with an oleaginous kale extract--a pilot study
2013 · kale group · Adults with non-exudative age-related macular degeneration; age range and sex not reported
10 mg4 weeks—
Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women
2018 · Group X—xanthophylls · Postmenopausal women aged 50–70 years
6 mg240 days—
Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women
2018 · Group X+A—anthocyanines and xanthophylls · Postmenopausal women aged 50–70 years
6 mg240 days—
Systemic Effects of Prenatal Carotenoid Supplementation in the Mother and her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial -Report Number 1
2023 · Carotenoid group · First-trimester pregnant subjects
10 mg240 days—
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease
2022 · active group · People with mild-moderate Alzheimer's disease; age and sex not reported
10 mg1 year50
Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study
2024 · LZ group · Children aged 5–12 years, male and female
10 mg180 days40
Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults
2003 · spread A · healthy adults
450 mcg11 weeks35
Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults
2003 · spread B · healthy adults
1.24 mg11 weeks35
Lutein supplementation increases breast milk and plasma lutein concentrations in lactating women and infant plasma concentrations but does not affect other carotenoids
2014 · low-dose group · Women aged 18 years or older, 4–6 weeks postpartum, continuously lactating and breastfeeding full-term singleton infants
6 mg6 weeks29
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration
2012 · 10 mg/day lutein plus 10 mg/day zeaxanthin · Adults aged 50–79 with early age-related macular degeneration
10 mg48 weeks27
Lutein supplementation increases breast milk and plasma lutein concentrations in lactating women and infant plasma concentrations but does not affect other carotenoids
2014 · high-dose group · Women aged 18 years or older, 4–6 weeks postpartum, continuously lactating and breastfeeding full-term singleton infants
12 mg6 weeks26
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973
2011 · 8 mg Zx plus 9 mg lutein · Patients with mild-to-moderate age-related macular degeneration, mean age 74.9 years; 57 men and 3 women across the study
9 mg1 year25
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration
2014 · Group 2 · People with early age-related macular degeneration; age and sex not stated
10 mg1 year21
Epilutein for Early-Stage Age-Related Macular Degeneration: A Randomized and Prospective Study
2017 · group 1 · Adults with early-stage age-related macular degeneration; mean age 69.4 years; sex not reported
2 mg60 days21
Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults
2010 · lutein plus green tea extract group · Men and postmenopausal women aged 50–70 years in good health
12 mg16 weeks20
Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements
2015 · FloraGLO group · Healthy Japanese adults aged 20 years and older, without ocular or systemic pathologies
10.5 mg26 weeks18
Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements
2015 · XanMax group · Healthy Japanese adults aged 20 years and older, without ocular or systemic pathologies
10.4 mg26 weeks18
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration
2014 · Group 1 · People with early age-related macular degeneration; age and sex not stated
20 mg1 year17
Goji Berry Intake Increases Macular Pigment Optical Density in Healthy Adults: A Randomized Pilot Trial
2021 · LZ supplement group · Healthy men and women aged 45–65 years with normal macular condition and no signs of drusen or early AMD
6 mg90 days15
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration
2014 · Group 3 · People with early age-related macular degeneration; age and sex not stated
3 mg1 year14
Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women
2006 · mixed carotenoids · Healthy, nonsmoking postmenopausal women aged 50–70 years
4 mg8 weeks—
Supplementation with all three macular carotenoids: response, stability, and safety
2011 · intervention (I group) · healthy adults; age and sex not specified
5.9 mg26 weeks—
The impact of macular pigment augmentation on visual performance using different carotenoid formulations
2012 · group 1 · Adults, 19–64 years (mean age 51 years), 19 male and 17 female across the study; condition not specified
20 mg26 weeks—
The impact of macular pigment augmentation on visual performance using different carotenoid formulations
2012 · group 2 · Adults, 19–64 years (mean age 51 years), 19 male and 17 female across the study; condition not specified
10 mg26 weeks—
Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial
2013 · group 1 · Individuals with nonexudative age-related macular degeneration; age and sex not specified
10 mg1 year—
Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial
2015 · lutein (10 mg)+zeaxanthin (10 mg) · Patients with early age-related macular degeneration
10 mg2 years—
The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial
2015 · Macushield, Alzheimer's disease patients · Adults with Alzheimer's disease; age range and sex not stated
10 mg26 weeks—
The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial
2015 · Macushield, age-similar control subjects · Age-similar control subjects; age range and sex not stated
10 mg26 weeks—
Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration
2015 · Group 1 · People with early age-related macular degeneration; age and sex not specified
20 mg3 years—
Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration
2015 · Group 2 · People with early age-related macular degeneration; age and sex not specified
10 mg3 years—
Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration
2015 · Group 3 · People with early age-related macular degeneration; age and sex not specified
3 mg3 years—
Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids
2015 · lutein and antioxidant supplement in combination with PUFA · Patients with age-related maculopathy
10 mg26 weeks—
The effects of lutein and zeaxanthin on resting state functional connectivity in older Caucasian adults: a randomized controlled trial
2020 · Lutein and zeaxanthin supplement · Community-dwelling older adults, mean age 72 years
10 mg1 year—
Lack of a Synergistic Effect on Cardiometabolic and Redox Markers in a Dietary Supplementation with Anthocyanins and Xanthophylls in Postmenopausal Women
2019 · Group X (xanthophylls) · Women aged 50–70 years, postmenopausal for more than two years, with BMI 25–33 kg/m²
6 mg243 days—
Lack of a Synergistic Effect on Cardiometabolic and Redox Markers in a Dietary Supplementation with Anthocyanins and Xanthophylls in Postmenopausal Women
2019 · Group A+X (anthocyanins + xanthophylls) · Women aged 50–70 years, postmenopausal for more than two years, with BMI 25–33 kg/m²
6 mg243 days—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 lutein plus zeaxanthin · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye
10 mg5 years—
Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study
2013 · D2 (twice daily) · Patients with non-exudative age-related macular degeneration; age and sex not specified
20 mg1 year55
Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study
2013 · D1 (once daily) · Patients with non-exudative age-related macular degeneration; age and sex not specified
10 mg1 year50
[Metabolic estimation of efficiency of vitamin and mineral complexes in qualified athletes]
2021 · main group · Professional athletes in cyclic sports; age and sex not stated
4.5 mg30 days42
Dietary supplementation with a natural carotenoid mixture decreases oxidative stress
2003 · Fish oil plus natural carotenoid mixture · Healthy, free-living, nonsmoking adults
4.4 mg3 weeks31
Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study
2022 · 4Nutri group · Young, healthy participants; age range and sex not stated
1.85 mg3 weeks20
Lutein Complex Supplementation Increases Ocular Blood Flow Biomarkers in Healthy Subjects
2019 · lutein phytochemicals complex · Healthy women, mean age 36.8 ± 12.1 years
10 mg3 weeks16
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 lutein/zeaxanthin plus DHA/EPA · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye
10 mg5 years—